How much does a box of entrectinib cost? Are there price differences in different regions or pharmacies?

Entrectinib is a tyrosine kinase inhibitor (TKI), mainly used to treat patients with NTRK gene fusion-positive and ROS1-positive advanced or metastatic solid tumors. As a broad-spectrum targeted drug, entrectinib has shown good efficacy in a variety of solid tumor types. It is currently on the market in China and has been successfully included in medical insurance, allowing patients to obtain the drug at a lower cost.

In China, the original drug price of entrectinib is about 20,000 yuan, but since it has been included in medical insurance, patients who meet the conditions for medical insurance reimbursement can enjoy a certain percentage of cost reduction. Specific medical insurance reimbursement standards may vary depending on regional policies, and patients are usually required to meet specific indications and have a prescription issued at a designated medical institution. It is recommended that patients consult their local hospital or medical insurance department before purchasing drugs to obtain the latest price and reimbursement policy information.

Compared with domestic original drugs, there are cheaper generic drugs on the foreign market, such as the Lao version of entrectinib, which has a specification of 100mg*60 tablets and sells for about more than 1,000 yuan. Although the ingredients of these generic drugs are basically the same as those of the original drugs, due to different production standards, approval processes and regulatory systems in different countries, patients should be cautious when choosing and consider whether to use generic drugs under the guidance of a doctor.

Overall, entrectinib provides patients with a more economical treatment option after entering medical insurance, but the price and reimbursement ratio may vary in different regions. For patients in need of treatment, it is recommended to give priority to purchasing drugs covered by medical insurance through formal channels, and pay close attention to changes in medical insurance policies to ensure the best economic support and treatment effects.

Reference materials:https://www.roche.com/products/rozlytrek